Effect of ropivacaine via trans-cricothyroid membrane injection on extubation response with patients undergoing maxillary and mandibular fracture

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002861

Enrollment

Unknown

Registered

2012-12-24

Start date

2012-03-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

maxillary and mandibular fracture

Interventions

dicaine group:dicaine topical anesthesia through cricothyroid membrane

ropovacaine group:Ropivacaine topical anesthesia through cricothyroid membrane

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 150 patients aged 20-60 years, ASA I-II, who required general anesthesia with nasotracheal intubation for maxillary and mandibular fracture surgery.

Exclusion criteria

Exclusion criteria: Patients who were complicated with cardiovascular disease, basal skull fracture, respiratory infection, nasal malformation, mental disorders, those with smoking history and those who had gastroesophageal reflux, hiatal hernia, esophageal disease and pharyngeal and epiglottic tumors were excluded.

Design outcomes

Primary

Measure	Time frame
incidence of cough;grade of cough;	—

Secondary

Measure	Time frame
blood pressure;Heart rate;	—

Countries

China

Contacts

Public ContactGao Wei

gaowei20055@126.com+86 0451-86605029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026